$IVFH Balance Sheet | Understand Stock

$IVFH

$0.23 -$0.01 (5.02%) Close

$IVFH Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated Balance Sheets

In millions of USD, except per-share amounts

	Q2 FY2026 As of Jun 30, 2026	Q1 FY2026 As of Mar 31, 2026	Q4 FY2025 As of Dec 31, 2025	Q3 FY2025 As of Sep 30, 2025	Q2 FY2025 As of Jun 30, 2025	Q1 FY2025 As of Mar 31, 2025	Q4 FY2024 As of Dec 31, 2024	Q3 FY2024 As of Sep 30, 2024	Q2 FY2024 As of Jun 30, 2024	Q1 FY2024 As of Mar 31, 2024	Q4 FY2023 As of Dec 31, 2023	Q3 FY2023 As of Sep 30, 2023	Q2 FY2023 As of Jun 30, 2023	Q1 FY2023 As of Mar 31, 2023	Q4 FY2022 As of Dec 31, 2022	Q3 FY2022 As of Sep 30, 2022	Q2 FY2022 As of Jun 30, 2022	Q1 FY2022 As of Mar 31, 2022	Q4 FY2021 As of Dec 31, 2021	Q3 FY2021 As of Sep 30, 2021
ASSETS
Current assets
Cash and cash equivalents
Cash, restricted
Accounts receivable, net
Inventory, net
Other current assets
Asset held for sale - discontinued operations
Current assets - discontinued operations
Total current assets
Property and equipment, net
Investments
Right of use assets - operating leases, net
Right of use assets - finance leases, net
Other amortizable intangible assets, net
Goodwill and other unamortizable intangible assets
Tradenames and other unamortizable intangible assets
Amortizable intangible assets, net
Indefinite-lived intangible assets
Other noncurrent assets
Noncurrent assets - discontinued operations
Total assets

LIABILITIES AND STOCKHOLDERS’ EQUITY
Current liabilities
Accounts payable and accrued liabilities
Accounts payable
Accrued payroll
Accrued liabilities
Total accounts payable and accrued liabilities
Accrued separation costs - related parties, current portion
Accrued interest
Deferred revenue
Line of Credit
Stock appreciation rights liability
Notes payable, current portion
Lease liability - operating leases, current
Lease liability - finance leases, current
Contingent liability, current
Current liabilities - discontinued operations
Total current liabilities
Accrued interest, long term portion
Note payable non-current
Accrued separation costs - related parties, non-current
Lease liability - operating leases, non-current
Lease liability - finance leases, non-current
Contingent liability - long-term
Noncurrent liabilities - discontinued operations
Total liabilities
Commitments & contingencies (see note 18)
Stockholders’ equity
Common stock: $0.0001 par value; 500,000,000 shares authorized; 57,493,776 shares issued, and 54,649,479 shares outstanding at June 30, 2026 and December 31, 2025, respectively
Common stock to be issued 0 and 738,032 shares at December 31, 2025 and 2024, respectively
Additional paid-in capital
Treasury stock: 2,644,297 shares outstanding at June 30, 2026 and December 31, 2025
Accumulated deficit
Total stockholders’ equity
Total liabilities and stockholders’ equity

Comments